cialis generico venta online pillole di kamatra http://web.taftcollege.edu/gasb/gasb2/dl...
cialis online sicuro forum vardenafil rezeptfrei cialis sicuro
apoteket viagra proscar kosten generique cialis efficace
vrai viagra viagra fabriqué inde cialis 5mg generika clomiphene citrate 50 mg simili viagra comprar viagra em portugal cialis mit rezept kamagra oral jelly billig prix du cialis en france

Archive | Oral Cancer News RSS feed for this section

Immune-related gene may predispose to HPV-related cancer

23. October 2014

0 Comments

Source: bcm.edu Author: Julia Parsons   An international coalition of cancer specialists led by a researcher now at Baylor College of Medicine has identified an immune related gene called transforming growth factor beta receptor 1 (TGFBR1) that appears to play an important role in determining whether a person develops a cancer related to human papilloma […]

Continue reading...

Mandibular reconstruction using plates prebent to fit rapid prototyping 3-dimensional printing models ameliorates contour deformity

23. October 2014

0 Comments

Source: 7thspace.com Authors: Masaki Azuma, Toru Yanagawa, Naomi Ishibash Kanno, Fumihiko Uchida, Takaaki Ito, Kenji Yamagata, Shogo Hasegawa, Kaoru Sasaki, Koji Adachi, Katsuhiko Tabuchi, Mitsuru Sekido and Hiroki Bukawa   Recently, medical rapid prototyping (MRP) models, fabricated with computer-aided design and computer-aided manufacture (CAD/CAM) techniques, have been applied to reconstructive surgery in the treatment of […]

Continue reading...

Critical Outcome Technologies and MD Anderson Cancer Center to evaluate COTI-2 in treating head and neck cancers

23. October 2014

0 Comments

Source: www.marketwatch.com Author: press release Critical Outcome Technologies Inc. (“COTI”), the bioinformatics and accelerated drug discovery company, announced today that it recently executed a material transfer agreement (“MTA”) with Dr. Jeffery Myers, MD, PhD, FACS of The University of Texas MD Anderson Cancer Center for the continued evaluation of COTI-2 in the potential treatment of […]

Continue reading...

Image cytometry may have roll in oral cancer screening

17. October 2014

0 Comments

Source: http://cebp.aacrjournals.org Author: Calum MacAulay, Martial Guillaud, Lewei Zhang, Catherine Poh, and Miriam Rosin   Abstract: Oral cancer like many epithelial cancers which are readily accessible are much more treatable if caught in their early pre-invasive/minimally invasive stages. The oral cavity is easily examined and sampled. In British Columbia we have established an Oral Cancer Prevention Program […]

Continue reading...

Cigarette smoking caused 14 million serious diseases in 2009

14. October 2014

0 Comments

Source: www.medscape.com Author: Larry Hand Cigarette smoking remains a major cause of preventable diseases in the United States, with at least 14 million serious medical conditions attributable to smoking in 2009, according to an article published online October 13 in JAMA Internal Medicine. “These estimates demonstrate that smoking accounts for millions of serious medical conditions […]

Continue reading...

Proteomic analysis of oral/head and neck cancer

10. October 2014

0 Comments

Source: http://cancerres.aacrjournals.org Author: Shen Hu, Lifeng Zhang, Jiang Jiang, Martha Arellano-Garcia, and David Wong   Abstract: The stagnant survival rates over the past few decades for patients with oral/head and neck squamous cell carcinoma (OSCC/HNSCC) emphasize the need for identifying novel diagnostic and therapeutic targets based on molecular profiling of the tumor. In this study, we have […]

Continue reading...

Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling

10. October 2014

0 Comments

Source: http://cancerres.aacrjournals.org Authors: Faina Linkov, Alex Lisovich, Zoya Yurkovetsky, Adele Marrangoni, Lyudmila Velikokhatnaya, Brian Nolen, Matthew Winans, William Bigbee, Jill Siegfried, Anna Lokshin, and Robert Ferris Abstract: Squamous cell carcinoma of the head and neck cancer (SCCHN) is an aggressive disease which has been linked to altered immune, inflammatory, and angiogenesis responses. A better understanding of […]

Continue reading...

Alcohol drinking in never-tobacco users and cigarette smoking in never drinkers: pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium

10. October 2014

0 Comments

Source: http://cancerres.aacrjournals.org Authors: Paolo Boffetta, Mia Hasibe & On Behalf Of INHANCE Consortium   Abstract: Cigarette smoking and alcohol drinking account for at least 75% of head and neck cancers. A precise understanding of the independent effect of each of these factors in the absence of the other has important implications, in terms of elucidating the mechanisms […]

Continue reading...

E-cigarette laws may be harder to regulate than originally thought

7. October 2014

0 Comments

Source: apnews.com or ap.org Author: Summer Ballentine & Michael Felberbaum   JEFFERSON CITY, Mo. (AP) – In a rush to keep electronic cigarettes out of children’s hands while the federal government creeps forward with a proposed national ban for minors, experts say that many states are passing laws that could mean fewer restrictions on the […]

Continue reading...

Number of immune cells in tumors could soon help predict and treat cancers

26. September 2014

0 Comments

Source: www.science20.com Authors: Emma King, University of Southampton and Christian Ottensmeier, University of Southampton Immune cells in the blood primarily defend us against infection. But we’re now learning that these cells can also keep us free from cancer. Patients with less efficient immune systems such as organ transplant recipients or those with untreated HIV, for […]

Continue reading...